n | % | |
---|---|---|
Age (years) | ||
Mean (SD) | 64.3 (9.6) | |
Gender | ||
Male | 20 | 66.7 |
Female | 10 | 33.3 |
Karnofsky PS (median, range) | 80 (60–90) | |
Primary site | ||
Lung | 14 | 46.7 |
Breast | 7 | 23.3 |
Prostate | 3 | 10.0 |
Kidney | 1 | 3.3 |
Other | 5 | 16.7 |
Site of spinal metastases | ||
Thoracic | 18 | 60.0 |
Lumbar | 12 | 40.0 |
Number metastases | ||
Mean (range) | 2.8 (1–11) | |
Solitary | 13 | 43.3 |
Multiple | 17 | 56.7 |
Concomitant metastases at baseline | ||
Visceral | 12 | 40.0 |
Brain | 3 | 10.0 |
Lung | 7 | 23.3 |
Tissue | 8 | 26.7 |
Surgical corset | 16 | 53.3 |
Bisphosphonates before RT | 28 | 93.3 |
Antihormonal therapy before RT | 3 | 10.0 |
Chemotherapy before RT | 20 | 66.7 |
Pathological fractures at baseline | 4 | 13.3 |